- Home
- PHAT vs ZUMZ Comparison
PHAT vs ZUMZ Comparison
Compare PHAT & ZUMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- ZUMZ
- Stock Information
- Founded
- PHAT 2018
- ZUMZ 1978
- Country
- PHAT United States
- ZUMZ United States
- Employees
- PHAT N/A
- ZUMZ N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- ZUMZ Clothing/Shoe/Accessory Stores
- Sector
- PHAT Health Care
- ZUMZ Consumer Discretionary
- Exchange
- PHAT Nasdaq
- ZUMZ Nasdaq
- Market Cap
- PHAT 465.0M
- ZUMZ 401.1M
- IPO Year
- PHAT 2019
- ZUMZ 2005
- Fundamental
- Price
- PHAT $6.96
- ZUMZ $15.47
- Analyst Decision
- PHAT Strong Buy
- ZUMZ Hold
- Analyst Count
- PHAT 4
- ZUMZ 2
- Target Price
- PHAT $23.00
- ZUMZ $22.00
- AVG Volume (30 Days)
- PHAT 971.9K
- ZUMZ 288.2K
- Earning Date
- PHAT 03-06-2025
- ZUMZ 03-13-2025
- Dividend Yield
- PHAT N/A
- ZUMZ N/A
- EPS Growth
- PHAT N/A
- ZUMZ N/A
- EPS
- PHAT N/A
- ZUMZ N/A
- Revenue
- PHAT $26,270,000.00
- ZUMZ $891,864,000.00
- Revenue This Year
- PHAT $7,622.43
- ZUMZ $4.32
- Revenue Next Year
- PHAT $236.87
- ZUMZ $2.19
- P/E Ratio
- PHAT N/A
- ZUMZ N/A
- Revenue Growth
- PHAT N/A
- ZUMZ 2.07
- 52 Week Low
- PHAT $6.07
- ZUMZ $12.90
- 52 Week High
- PHAT $19.71
- ZUMZ $31.37
- Technical
- Relative Strength Index (RSI)
- PHAT 37.02
- ZUMZ 29.16
- Support Level
- PHAT $6.36
- ZUMZ $15.18
- Resistance Level
- PHAT $7.20
- ZUMZ $19.64
- Average True Range (ATR)
- PHAT 0.48
- ZUMZ 0.85
- MACD
- PHAT 0.08
- ZUMZ -0.30
- Stochastic Oscillator
- PHAT 30.48
- ZUMZ 6.16
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.